Kuske S, Moschinski K, Andrich S, Stephan A, Gnass I, Sirsch E, Icks A
Institute for Health Services Research and Health Economics, Faculty of Medicine, Economics, Heinrich-Heine-University, Moorenstraße 5, 40225, Düsseldorf, Germany.
Paul Langerhans Group for Health Services Research and Health Economics, German Diabetes Center (DDZ), Leibniz Institute for Diabetes Research, Heinrich-Heine-University, Auf'm Hennekamp 65, 40225, Düsseldorf, Germany.
Syst Rev. 2016 Jul 13;5(1):113. doi: 10.1186/s13643-016-0296-3.
Studies show that people with dementia do not receive the same amount of analgesia after a hip or pelvic fracture compared to those without cognitive impairment. However, there is no systematic review that shows to what extent and how drug-based pain management is performed for people with dementia following a hip or pelvic fracture. The aim of this systematic review is to identify studies addressing drug-based pain management for people with dementia who have had a hip or pelvic fracture for which they had either an operation or conservative treatment. We will analyse to what extent and how the drug-based pain treatment for people with dementia is performed across all settings and how it is assessed in the studies.
The development of this systematic review protocol was guided by the PRISMA-P requirements, which will be taken into consideration during the review procedure. MEDLINE, EMBASE, CINAHL, Web of Knowledge and ScienceDirect will be searched, using keywords such as "analgesia", "dementia", "cognitive impairment", "pain treatment", "hip fracture" or "pelvic fracture". Publications published up to January 2016 will be included. The data extraction and a content analysis will be carried out systematically, followed by a critical appraisal.
This review will provide a valuable overview on the current evidence on drug-based pain management for PwD in all settings who were conservatively treated after a hip or pelvic fracture. The review may expose a need to enhance pain management for PwD. It may also provide motivation for healthcare providers and policymakers to give this topic their attention and to facilitate further research by considering aspects of care transitions in all settings.
PROSPERO CRD42016037309.
研究表明，与无认知障碍者相比，痴呆患者在髋部或骨盆骨折后未得到同等程度的镇痛治疗。然而，尚无系统评价表明，髋部或骨盆骨折后的痴呆患者在多大程度上以及如何进行基于药物的疼痛管理。本系统评价的目的是识别针对髋部或骨盆骨折后接受手术或保守治疗的痴呆患者进行基于药物的疼痛管理的研究。我们将分析在所有环境中，针对痴呆患者的基于药物的疼痛治疗在多大程度上以及如何实施，以及在研究中如何进行评估。
本系统评价方案的制定以PRISMA-P要求为指导，在评价过程中将予以考虑。将检索MEDLINE、EMBASE、CINAHL、Web of Knowledge和ScienceDirect，使用“镇痛”、“痴呆”、“认知障碍”、“疼痛治疗”、“髋部骨折”或“骨盆骨折”等关键词。纳入截至2016年1月发表的文献。将系统地进行数据提取和内容分析，随后进行批判性评价。
本评价将提供关于髋部或骨盆骨折后接受保守治疗的所有环境中的痴呆患者基于药物的疼痛管理的现有证据的宝贵概述。该评价可能揭示加强痴呆患者疼痛管理的必要性。它还可能促使医疗保健提供者和政策制定者关注这一主题，并通过考虑所有环境中的护理过渡方面来促进进一步研究。
PROSPERO CRD42016037309。
